|
1.Hsing, A. W., Tsao, L., and Devesa, S. S. (2000) International trends and patterns of prostate cancer incidence and mortality. International journal of cancer 85, 60-67
2.Kishimoto, T. (2010) IL-6: from its discovery to clinical applications. International immunology 22, 347-352
3.Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., and Kishimoto, T. (1988) Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science (New York, N.Y.) 241, 825-828
4.Martin, W. J., and Miller, J. F. (1968) Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. The Journal of experimental medicine 128, 855-874
5.Claman, H. N., Chaperon, E. A., and Selner, J. C. (1968) Thymus-marrow immunocompetence. 3. The requirement for living thymus cells. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 127, 462-466
6.Kishimoto, T. (1985) Factors affecting B-cell growth and differentiation. Annual review of immunology 3, 133-157
7.Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., and Kishimoto, T. (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157
8.Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., and Kishimoto, T. (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573-581
9.Hong, D. S., Angelo, L. S., and Kurzrock, R. (2007) Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110, 1911-1928
10.Kishimoto, T., Taga, T., and Akira, S. (1994) Cytokine signal transduction. Cell 76, 253-262
11.Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S., and Kishimoto, T. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929
12.Kimura, A., and Kishimoto, T. (2010) IL-6: regulator of Treg/Th17 balance. European journal of immunology 40, 1830-1835
13.Tanaka, T., Narazaki, M., and Kishimoto, T. (2012) Therapeutic targeting of the interleukin-6 receptor. Annual review of pharmacology and toxicology 52, 199-219
14.Ma, C. S., Deenick, E. K., Batten, M., and Tangye, S. G. (2012) The origins, function, and regulation of T follicular helper cells. The Journal of experimental medicine 209, 1241-1253
15.Heinrich, P. C., Castell, J. V., and Andus, T. (1990) Interleukin-6 and the acute phase response. The Biochemical journal 265, 621-636
16.Tanaka, T., and Kishimoto, T. (2014) The biology and medical implications of interleukin-6. Cancer immunology research 2, 288-294
17.Abdul Rahim, S. N., Ho, G. Y., and Coward, J. I. (2015) The role of interleukin-6 in malignant mesothelioma. Translational lung cancer research 4, 55-66
18.Chun, J. Y., Nadiminty, N., Dutt, S., Lou, W., Yang, J. C., Kung, H. J., Evans, C. P., and Gao, A. C. (2009) Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research 15, 4815-4822
19.Siegall, C. B., Schwab, G., Nordan, R. P., FitzGerald, D. J., and Pastan, I. (1990) Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer research 50, 7786-7788
20.Lee, S. O., Lou, W., Hou, M., de Miguel, F., Gerber, L., and Gao, A. C. (2003) Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research 9, 370-376
21.Ueda, T., Bruchovsky, N., and Sadar, M. D. (2002) Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. The Journal of biological chemistry 277, 7076-7085
22.Aaronson, D. S., Muller, M., Neves, S. R., Chung, W. C., Jayaram, G., Iyengar, R., and Ram, P. T. (2007) An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells. Molecular and cellular endocrinology 270, 50-56
23.Zhu, M. L., and Kyprianou, N. (2008) Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. Endocrine-related cancer 15, 841-849
24.Lin, L. C., Gao, A. C., Lai, C. H., Hsieh, J. T., and Lin, H. (2017) Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes. Cancer letters 391, 74-82
25.Satyanarayana, A., and Kaldis, P. (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28, 2925-2939
26.Hochegger, H., Takeda, S., and Hunt, T. (2008) Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nature reviews. Molecular cell biology 9, 910-916
27.Hellmich, M. R., Pant, H. C., Wada, E., and Battey, J. F. (1992) Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proceedings of the National Academy of Sciences of the United States of America 89, 10867-10871
28.Tsai, L. H., Takahashi, T., Caviness, V. S., Jr., and Harlow, E. (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (Cambridge, England) 119, 1029-1040
29.Ino, H., Ishizuka, T., Chiba, T., and Tatibana, M. (1994) Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase, in the mature and developing mouse central and peripheral nervous systems. Brain research 661, 196-206
30.Dhavan, R., and Tsai, L. H. (2001) A decade of CDK5. Nature reviews. Molecular cell biology 2, 749-759
31.Dhariwala, F. A., and Rajadhyaksha, M. S. (2008) An unusual member of the Cdk family: Cdk5. Cellular and molecular neurobiology 28, 351-369
32.Gupta, A., Sanada, K., Miyamoto, D. T., Rovelstad, S., Nadarajah, B., Pearlman, A. L., Brunstrom, J., and Tsai, L. H. (2003) Layering defect in p35 deficiency is linked to improper neuronal-glial interaction in radial migration. Nature neuroscience 6, 1284-1291
33.Paglini, G., Pigino, G., Kunda, P., Morfini, G., Maccioni, R., Quiroga, S., Ferreira, A., and Caceres, A. (1998) Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. The Journal of neuroscience : the official journal of the Society for Neuroscience 18, 9858-9869
34.Pareek, T. K., and Kulkarni, A. B. (2006) Cdk5: a new player in pain signaling. Cell cycle (Georgetown, Tex.) 5, 585-588
35.Spiegelman, B. M. (1997) Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity. European journal of medical research 2, 457-464
36.Lalioti, V., Pulido, D., and Sandoval, I. V. (2010) Cdk5, the multifunctional surveyor. Cell cycle (Georgetown, Tex.) 9, 284-311
37.Sun, D., Leung, C. L., and Liem, R. K. (1996) Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. The Journal of biological chemistry 271, 14245-14251
38.Tsai, L. H., Delalle, I., Caviness, V. S., Jr., Chae, T., and Harlow, E. (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423
39.Lew, J., Huang, Q. Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., and Wang, J. H. (1994) A brain-specific activator of cyclin-dependent kinase 5. Nature 371, 423-426
40.Ishiguro, K., Kobayashi, S., Omori, A., Takamatsu, M., Yonekura, S., Anzai, K., Imahori, K., and Uchida, T. (1994) Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS letters 342, 203-208
41.Lee, M. S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., and Tsai, L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364
42.Ko, J., Humbert, S., Bronson, R. T., Takahashi, S., Kulkarni, A. B., Li, E., and Tsai, L. H. (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. The Journal of neuroscience : the official journal of the Society for Neuroscience 21, 6758-6771
43.Hallows, J. L., Chen, K., DePinho, R. A., and Vincent, I. (2003) Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 23, 10633-10644
44.Tang, D., Yeung, J., Lee, K. Y., Matsushita, M., Matsui, H., Tomizawa, K., Hatase, O., and Wang, J. H. (1995) An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. The Journal of biological chemistry 270, 26897-26903
45.Gervasi, C., and Szaro, B. G. (1995) The Xenopus laevis homologue to the neuronal cyclin-dependent kinase (cdk5) is expressed in embryos by gastrulation. Brain research. Molecular brain research 33, 192-200
46.Philpott, A., Tsai, L., and Kirschner, M. W. (1999) Neuronal differentiation and patterning in Xenopus: the role of cdk5 and a novel activator xp35.2. Developmental biology 207, 119-132
47.Hellmich, M. R., Kennison, J. A., Hampton, L. L., and Battey, J. F. (1994) Cloning and characterization of the Drosophila melanogaster CDK5 homolog. FEBS letters 356, 317-321
48.Zheng, M., Leung, C. L., and Liem, R. K. (1998) Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. Journal of neurobiology 35, 141-159
49.Wu, D. C., Yu, Y. P., Lee, N. T., Yu, A. C., Wang, J. H., and Han, Y. F. (2000) The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains. Neurochemical research 25, 923-929
50.Rosales, J. L., and Lee, K. Y. (2006) Extraneuronal roles of cyclin-dependent kinase 5. BioEssays : news and reviews in molecular, cellular and developmental biology 28, 1023-1034
51.Lee, K. Y., Rosales, J. L., Lee, B. C., Chung, S. H., Fukui, Y., Lee, N. S., Lee, K. Y., and Jeong, Y. G. (2004) Cdk5/p35 expression in the mouse ovary. Molecules and cells 17, 17-22
52.Rosales, J. L., Lee, B. C., Modarressi, M., Sarker, K. P., Lee, K. Y., Jeong, Y. G., Oko, R., and Lee, K. Y. (2004) Outer dense fibers serve as a functional target for Cdk5.p35 in the developing sperm tail. The Journal of biological chemistry 279, 1224-1232
53.Wei, F. Y., Nagashima, K., Ohshima, T., Saheki, Y., Lu, Y. F., Matsushita, M., Yamada, Y., Mikoshiba, K., Seino, Y., Matsui, H., and Tomizawa, K. (2005) Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nature medicine 11, 1104-1108
54.Gao, C., Negash, S., Guo, H. T., Ledee, D., Wang, H. S., and Zelenka, P. (2002) CDK5 regulates cell adhesion and migration in corneal epithelial cells. Molecular cancer research : MCR 1, 12-24
55.Zhang, J., Krishnamurthy, P. K., and Johnson, G. V. (2002) Cdk5 phosphorylates p53 and regulates its activity. Journal of neurochemistry 81, 307-313
56.Lin, H., Chen, M. C., Chiu, C. Y., Song, Y. M., and Lin, S. Y. (2007) Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. The Journal of biological chemistry 282, 2776-2784
57.Hsu, F. N., Chen, M. C., Chiang, M. C., Lin, E., Lee, Y. T., Huang, P. H., Lee, G. S., and Lin, H. (2011) Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. The Journal of biological chemistry 286, 33141-33149
58.Contreras-Vallejos, E., Utreras, E., and Gonzalez-Billault, C. (2012) Going out of the brain: non-nervous system physiological and pathological functions of Cdk5. Cellular signalling 24, 44-52
59.Liebl, J., Weitensteiner, S. B., Vereb, G., Takacs, L., Furst, R., Vollmar, A. M., and Zahler, S. (2010) Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis. The Journal of biological chemistry 285, 35932-35943
60.Liebl, J., Krystof, V., Vereb, G., Takacs, L., Strnad, M., Pechan, P., Havlicek, L., Zatloukal, M., Furst, R., Vollmar, A. M., and Zahler, S. (2011) Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases. Angiogenesis 14, 281-291
61.Kuo, H. S., Hsu, F. N., Chiang, M. C., You, S. C., Chen, M. C., Lo, M. J., and Lin, H. (2009) The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line. The Chinese journal of physiology 52, 23-30
62.Lin, E., Chen, M. C., Huang, C. Y., Hsu, S. L., Huang, W. J., Lin, M. S., Wu, J. C., and Lin, H. (2014) All-trans retinoic acid induces DU145 cell cycle arrest through Cdk5 activation. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 33, 1620-1630
63.Hsu, F. N., Chen, M. C., Lin, K. C., Peng, Y. T., Li, P. C., Lin, E., Chiang, M. C., Hsieh, J. T., and Lin, H. (2013) Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser(7)(2)(7) on STAT3 in prostate cancer cells. American journal of physiology. Endocrinology and metabolism 305, E975-986
64.Huang, P. H., Chen, M. C., Peng, Y. T., Kao, W. H., Chang, C. H., Wang, Y. C., Lai, C. H., Hsieh, J. T., Wang, J. H., Lee, Y. T., Lin, E., Yue, C. H., Wang, H. Y., You, S. C., and Lin, H. (2016) Cdk5 Directly Targets Nuclear p21CIP1 and Promotes Cancer Cell Growth. Cancer research 76, 6888-6900
65.Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. The American journal of pathology 146, 1029-1039
66.Rak, J., and Weitz, J. I. (2003) Heparin and angiogenesis: size matters! Arteriosclerosis, thrombosis, and vascular biology 23, 1954-1955
67.Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A., and Starovasnik, M. A. (1998) Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure (London, England : 1993) 6, 637-648
68.Grimmond, S., Lagercrantz, J., Drinkwater, C., Silins, G., Townson, S., Pollock, P., Gotley, D., Carson, E., Rakar, S., Nordenskjold, M., Ward, L., Hayward, N., and Weber, G. (1996) Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome research 6, 124-131
69.Shibuya, M. (2011) Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. Genes & cancer 2, 1097-1105
70.Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., and De Bruijn, E. A. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacological reviews 56, 549-580
71.J, G., Cq, W., Hh, F., Hy, D., Xl, X., Ym, X., By, W., and Dj, H. (2006) Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. Journal of cardiovascular pharmacology 47, 711-721
72.Ito, F. (2011) Foreword. Target therapy for cancer: anti-cancer drugs targeting growth-factor signaling molecules. Biological & pharmaceutical bulletin 34, 1773
73.Hagberg, C., Mehlem, A., Falkevall, A., Muhl, L., and Eriksson, U. (2013) Endothelial fatty acid transport: role of vascular endothelial growth factor B. Physiology (Bethesda, Md.) 28, 125-134
74.Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 13, 9-22
75.Koch, S., Tugues, S., Li, X., Gualandi, L., and Claesson-Welsh, L. (2011) Signal transduction by vascular endothelial growth factor receptors. The Biochemical journal 437, 169-183
76.Ancelin, M., Buteau-Lozano, H., Meduri, G., Osborne-Pellegrin, M., Sordello, S., Plouet, J., and Perrot-Applanat, M. (2002) A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Proceedings of the National Academy of Sciences of the United States of America 99, 6023-6028
77.Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., and Carmeliet, G. (2002) Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mechanisms of development 111, 61-73
78.Ortega, N., Hutchings, H., and Plouet, J. (1999) Signal relays in the VEGF system. Frontiers in bioscience : a journal and virtual library 4, D141-152
79.Grothey, A., and Galanis, E. (2009) Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nature reviews. Clinical oncology 6, 507-518
80.Cai, C., Bottcher, M. C., Werner, J. A., and Mandic, R. (2010) Differential expression of VEGF121, VEGF165 and VEGF189 in angiomas and squamous cell carcinoma cell lines of the head and neck. Anticancer research 30, 805-810
81.Goel, H. L., and Mercurio, A. M. (2013) VEGF targets the tumour cell. Nature reviews. Cancer 13, 871-882
82.Bergers, G., and Benjamin, L. E. (2003) Tumorigenesis and the angiogenic switch. Nature reviews. Cancer 3, 401-410
83.Davis, D. W., McConkey, D. J., Abbruzzese, J. L., and Herbst, R. S. (2003) Surrogate markers in antiangiogenesis clinical trials. British journal of cancer 89, 8-14
84.Cristofanilli, M., Charnsangavej, C., and Hortobagyi, G. N. (2002) Angiogenesis modulation in cancer research: novel clinical approaches. Nature reviews. Drug discovery 1, 415-426
85.Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., and Keshet, E. (1998) Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proceedings of the National Academy of Sciences of the United States of America 95, 10820-10825
86.Roberts, E., Cossigny, D. A., and Quan, G. M. (2013) The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton. Prostate cancer 2013, 418340
87.Chen, J., De, S., Brainard, J., and Byzova, T. V. (2004) Metastatic properties of prostate cancer cells are controlled by VEGF. Cell communication & adhesion 11, 1-11
88.Menakuru, S. R., Brown, N. J., Staton, C. A., and Reed, M. W. (2008) Angiogenesis in pre-malignant conditions. British journal of cancer 99, 1961-1966
89.Spannuth, W. A., Sood, A. K., and Coleman, R. L. (2008) Angiogenesis as a strategic target for ovarian cancer therapy. Nature clinical practice. Oncology 5, 194-204
90.Kamrava, M., Bernstein, M. B., Camphausen, K., and Hodge, J. W. (2009) Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? Molecular bioSystems 5, 1262-1270
91.Nishida, N., Yano, H., Nishida, T., Kamura, T., and Kojiro, M. (2006) Angiogenesis in cancer. Vascular health and risk management 2, 213-219
92.Gilkes, D. M., Semenza, G. L., and Wirtz, D. (2014) Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nature reviews. Cancer 14, 430-439
93.Carmeliet, P., and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257
94.Palazon, A., Aragones, J., Morales-Kastresana, A., de Landazuri, M. O., and Melero, I. (2012) Molecular pathways: hypoxia response in immune cells fighting or promoting cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 18, 1207-1213
95.Moran, D. M., Mattocks, M. A., Cahill, P. A., Koniaris, L. G., and McKillop, I. H. (2008) Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. The Journal of surgical research 147, 23-33
96.Moran, D. M., Mayes, N., Koniaris, L. G., Cahill, P. A., and McKillop, I. H. (2005) Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 25, 445-457
97.Mori, S., Murakami-Mori, K., and Bonavida, B. (1999) Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochemical and biophysical research communications 257, 609-614
98.Morales, I., Farias, G., and Maccioni, R. B. (2010) Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 17, 202-204
99.Quintanilla, R. A., Orellana, D. I., Gonzalez-Billault, C., and Maccioni, R. B. (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Experimental cell research 295, 245-257
100.Lam, E., Choi, S. H., Pareek, T. K., Kim, B. G., and Letterio, J. J. (2015) Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727. Molecular immunology 67, 317-324
101.Ferrari, G., Cook, B. D., Terushkin, V., Pintucci, G., and Mignatti, P. (2009) Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. Journal of cellular physiology 219, 449-458
102.Huang, S. P., Wu, M. S., Shun, C. T., Wang, H. P., Lin, M. T., Kuo, M. L., and Lin, J. T. (2004) Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. Journal of biomedical science 11, 517-527
103.Guadagni, F., Ferroni, P., Palmirotta, R., Portarena, I., Formica, V., and Roselli, M. (2007) Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy. In vivo (Athens, Greece) 21, 147-161
104.Jung, Y. D., Liu, W., Reinmuth, N., Ahmad, S. A., Fan, F., Gallick, G. E., and Ellis, L. M. (2001) Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis 4, 155-162
105.Chae, K. S., Kang, M. J., Lee, J. H., Ryu, B. K., Lee, M. G., Her, N. G., Ha, T. K., Han, J., Kim, Y. K., and Chi, S. G. (2011) Opposite functions of HIF-alpha isoforms in VEGF induction by TGF-beta1 under non-hypoxic conditions. Oncogene 30, 1213-1228
106.Carmi, Y., Dotan, S., Rider, P., Kaplanov, I., White, M. R., Baron, R., Abutbul, S., Huszar, M., Dinarello, C. A., Apte, R. N., and Voronov, E. (2013) The role of IL-1beta in the early tumor cell-induced angiogenic response. Journal of immunology (Baltimore, Md. : 1950) 190, 3500-3509
107.Westra, J., Molema, G., and Kallenberg, C. G. (2010) Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications. Current medicinal chemistry 17, 254-263
108.Wei, L. H., Kuo, M. L., Chen, C. A., Chou, C. H., Lai, K. B., Lee, C. N., and Hsieh, C. Y. (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22, 1517-1527
109.Culig, Z., Steiner, H., Bartsch, G., and Hobisch, A. (2005) Interleukin-6 regulation of prostate cancer cell growth. Journal of cellular biochemistry 95, 497-505
110.Shimoyamada, H., Yazawa, T., Sato, H., Okudela, K., Ishii, J., Sakaeda, M., Kashiwagi, K., Suzuki, T., Mitsui, H., Woo, T., Tajiri, M., Ohmori, T., Ogura, T., Masuda, M., Oshiro, H., and Kitamura, H. (2010) Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. The American journal of pathology 177, 70-83
111.Sharma, M. R., Tuszynski, G. P., and Sharma, M. C. (2004) Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5. Journal of cellular biochemistry 91, 398-409
112.Xie, W., Wang, H., He, Y., Li, D., Gong, L., and Zhang, Y. (2014) CDK5 and its activator P35 in normal pituitary and in pituitary adenomas: relationship to VEGF expression. International journal of biological sciences 10, 192-199
113.Merk, H., Zhang, S., Lehr, T., Muller, C., Ulrich, M., Bibb, J. A., Adams, R. H., Bracher, F., Zahler, S., Vollmar, A. M., and Liebl, J. (2016) Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis. Oncotarget 7, 6088-6104
114.Antoniou, X., Gassmann, M., and Ogunshola, O. O. (2011) Cdk5 interacts with Hif-1alpha in neurons: a new hypoxic signalling mechanism? Brain research 1381, 1-10
115.Herzog, J., Ehrlich, S. M., Pfitzer, L., Liebl, J., Frohlich, T., Arnold, G. J., Mikulits, W., Haider, C., Vollmar, A. M., and Zahler, S. (2016) Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1alpha: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma. Oncotarget 7, 27108-27121
116.Meloche, J., Pflieger, A., Vaillancourt, M., Paulin, R., Potus, F., Zervopoulos, S., Graydon, C., Courboulin, A., Breuils-Bonnet, S., Tremblay, E., Couture, C., Michelakis, E. D., Provencher, S., and Bonnet, S. (2014) Role for DNA damage signaling in pulmonary arterial hypertension. Circulation 129, 786-797
117.Bettinger, B. T., Gilbert, D. M., and Amberg, D. C. (2004) Actin up in the nucleus. Nature reviews. Molecular cell biology 5, 410-415
118.de Lanerolle, P., Johnson, T., and Hofmann, W. A. (2005) Actin and myosin I in the nucleus: what next? Nature structural & molecular biology 12, 742-746
119.Misu, S., Takebayashi, M., and Miyamoto, K. (2017) Nuclear Actin in Development and Transcriptional Reprogramming. Frontiers in genetics 8, 27
120.Grosse, R., and Vartiainen, M. K. (2013) To be or not to be assembled: progressing into nuclear actin filaments. Nature reviews. Molecular cell biology 14, 693-697
|